Serum lipid profile improved by ultra-low doses of 17β-estradiol in elderly women

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 6, 2001, Pages 2757-2762

  Naessen, Tord ^a   Rodriguez Macias, Kenny ^a   Lithell, Hans ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; ESTRADIOL; ESTRONE SULFATE; FOLLITROPIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SEX HORMONE BINDING GLOBULIN; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ELDERLY CARE; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONE PROTEIN COMPLEX; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; HUMANS; LIPIDS; MIDDLE AGED; REFERENCE VALUES; SEX HORMONE-BINDING GLOBULIN; TRIGLYCERIDES;

EID: 0034977641     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.6.2757     Document Type: Article

References (40)

1. Lifetime risk of developing coronary heart disease
2. Menopause and risk factors for coronary heart disease
3. PEPI. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The postmenopausal estrogen/progestin interventions (PEPI) trial
4. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins
5. Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program follow-up study
6. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
7. Hormone therapy to prevent disease and prolong life in postmenopausal women
8. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study
9. Clinical review 27: Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women
10. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women
11. Carotid artery wall thickness in women treated with hormone replacement therapy
12. Inhibition of coronary artery atherosclerosis by 17-β estradiol in ovariectomized monkeys. Lack of an effect of added progesterone
13. Short-term estrogen augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilation in postmenopausal women
14. Low-density lipoproteins and risk for coronary artery disease
15. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women
16. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
17. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators
18. Changes in plasma lipoproteins during low-fat, high-carbohydrate diets: Effects of energy intake
19. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
20. Relationship between serum estradiol levels and the increases in high-density lipoprotein levels in postmenopausal women treated with oral estradiol
21. Coronary drug project report on clofibrate and niacin
22. Vaginal rings for continuous low-dose release of oestradiol in the treatment of urogenital atrophy
23. Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy
24. Bone loss in elderly women prevented by ultralow doses of parenteral 17β-estradiol
25. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
26. Low endogenous estrogen levels: Analytical problems and tissue sensitivity
27. Determination of total oestrone in peripheral serum from non pregnant humans
28. Methods for assessing whether change depends on initial value
29. Lipoprotein(a) and postmenopausal oestrogen
30. Reliability and interrelations among serum sex hormones in postmenopausal women
31. Associations between low levels of serum estradiol, bone density, and fractures among elderly women: The study of osteoporotic fractures
32. Endogenous hormones and the risk of hip and vertebral fractures among older women
33. Estrogen treatment of patients with established postmenopausal osteoporosis
34. Age-related changes in human oestrogen receptor α function and levels in osteoblasts
35. Sex steroid receptors in human myometrium and fibroids: Changes during the menstrual cycle and gonadotropin-releasing hormone treatment
36. Transvaginal sonography of the internal genital organs in postmenopausal women on low-dose estrogen treatment
37. Women's concerns with hormone replacement therapy: Compliance issues
38. The Heart and Estrogen/Progestin Replacement Study (HERS) in perspective: Results not very surprizing
39. Hormone replacement therapy with estradiol and risk of venous thromboembolism: A population-based case-control study
40. Low-dosage micronized 17 β-estradiol prevents bone loss in postmenopausal women